Segment Description: Colleen Kelley, MD, MPH, associate professor at the Emory University School of Medicine, describes barriers to the implementation of HIV pre-exposure prophylaxis.
Interview Transcript (modified slightly for readability):
Kelley: I do think we are seeing declines [in HIV incidence] in areas that have done a great job implementing pre-exposure prophylaxis. The issue is implementation. It's getting pre-exposure prophylaxis to the people who need it the most, and supporting them to be able to use it during times when they may be at risk for HIV. Implementation and access are big barriers. After that is successfully supporting people to persist on PrEP, to continue taking it through the period of time where they might be at risk for HIV. Currently I think those are the 3 biggest barriers: implementation, access, and persistence on pre-exposure prophylaxis.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512